2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Deceased Donor Kidney Transplantation
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: The Kidney Allocation System (KAS), implemented in 2014, increased offers of ABO type A2 donor kidneys to type O and B recipients, and A2B…2020 American Transplant Congress
Transplant and Cardiovascular Outcomes in Renal Transplant Recipients with Different Pre-Transplant Cardiovascular Risk
*Purpose: Renal transplant patients have higher cardiovascular (CV) risk compared to their peers. Pre-transplant CV risk factors may be amplified post-transplant, but little is known…2020 American Transplant Congress
Short Tandem Repeat (STR) Analysis Identifies a Cancer Transmitted from an Organ Donor to 4 Transplant Recipients
1UCSF, San Francisco, CA, 2Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA
*Purpose: Organ donors are systematically screened for infection, while screening for malignancy is less rigorous. The true incidence of donor-transmitted malignancies is unknown due to…2020 American Transplant Congress
Risk Factors for the Development of Avascular Necrosis: Single Center Experience
*Purpose: Avascular necrosis (AVN) is one of the most common bone complications after kidney transplantation. In recent years, it has become an important morbidity with…2020 American Transplant Congress
Protection Role of microRNA let-7 in Hepatic Ischemia Reperfusion Injury by Inhibiting JAK-STAT3 Pathway
*Purpose: Ischemia reperfusion injury (IRI) is an inevitable event in conventional organ transplant procedure and affects the prognosis in post-transplantation. Increasing evidence suggests that microRNA…2020 American Transplant Congress
Case Series of Belatacept for Calcineurin Inhibitor Sparing after Lung Transplantation
*Purpose: Belatacept is a recombinant soluble fusion protein which selectively blocks T-cell co-stimulation. It received initial FDA approval for prophylaxis of organ rejection in Epstein-Barr…2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
1UCSF, San Francisco, CA, 2UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…2020 American Transplant Congress
Incidence, Risk Factors, and Kidney Transplant Outcomes Associated with Post-Transplant Diabetes Mellitus
1Johns Hopkins University, Baltimore, MD, 2DDS Consortium, Baltimore, MD
*Purpose: Post-Transplant Diabetes Mellitus (PTDM) is a common complication after kidney transplant (KT). Most prior studies are single-center with short follow-up and inconsistent outcome ascertainment.…2020 American Transplant Congress
New Onset Diabetes after Transplant (NODAT) in Hispanic Kidney Transplant Recipients: A Multi-Center Retrospective Study
*Purpose: Hispanic ethnicity is one of the reported risk factors for NODAT in kidney transplant recipients (KTR). The purpose of our study is to determine…2020 American Transplant Congress
Long-Term Outcomes of Kidney Donors with Nephrolithiasis
*Purpose: Long-term outcomes data of living kidney donors (LKDs) with nephrolithiasis are limited. We assessed the clinical and structural findings and their association with long-term…
- « Previous Page
- 1
- …
- 401
- 402
- 403
- 404
- 405
- …
- 1683
- Next Page »